Items tagged with Scientific research
Researchers have uncovered a sequence of biological processes that occur in humans infected with the bacterium Mycobacterium tuberculosis as the infection progresses to pulmonary tuberculosis, according to new research published in PLOS Pathogens.
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene & Tropical Medicine.
A team of scientists led by the University of Southampton has taken an important step forward in research efforts that could one day lead to an effective vaccine against the world’s deadliest infectious disease.
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.
Mycobacterium tuberculosis (Mtb) is the causative agent of the serious lung disease, tuberculosis, that is widespread throughout the world. About one-third of the human population is infected with tuberculosis, which takes at least six months of daily drug treatment to cure. Unfortunately, there is an increasing prevalence of drug resistant strains of the disease.
Washington, DC – January 3, 2018 – Studies in mice and in tissue cultures suggest that giving vitamin C with tuberculosis drugs could reduce the unusually long time it takes these drugs to eradicate this pathogen. The research is published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.
Securing a TB-free future through the visionary research of the CDC’s Tuberculosis Trials Consortium (post)
January 10, 2018 – The Tuberculosis Trials Consortium (TBTC) is a global leader in research and development for better tools to prevent, diagnose, and treat tuberculosis (TB). Housed within the U.S. Centers for Disease Control and Prevention (CDC), the TBTC conducts clinical research of high public health relevance and is key to strengthening domestic and global campaigns to eliminate TB. TBTC studies have produced several notable breakthroughs, including a shorter regimen for preventing TB (3HP) using isoniazid and rifapentine. The Community Research Advisors Group (CRAG) produced this briefing document to raise awareness of the TBTC’s legacy of accomplishments; highlight major advances in TB care resulting from TBTC studies; and make the case for increasing funding for TB research at CDC in line with the goals of the U.S. National Action Plan for Combatting Multidrug-Resistant Tuberculosis.
Canadian researchers’ innovative work promises to make vaccines more effective against TB and other infectious diseases like the flu.
Page 29 of 35 · Total posts: 0←First 28 29 30 Last→